TC Biopharm Holdings PLC
13F holders, Q4 2024 (December 31)12holders +5
8new positions
4sold out
$0.63avg. 13F price*
At the end of Q4 2024, 12 institutions reported holding TC Biopharm Holdings PLC in their 13F filings, up 5 from Q3 2024. 8 opened new positions and 4 sold out. The largest holders were Cubist Systematic Strategies, LLC ($10K), Virtu Financial LLC ($10K) and HRT Financial LP ($9K).
- Company
- TC Biopharm Holdings PLC
- CUSIP
- 87807D509
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $32K |
| Exits | 4 | $46K |
All 13F filers, Q3 2024 → Q4 2024: 50,261 shares bought and 8,794 shares sold, net +41,467 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Cubist Systematic Strategies, LLC | 0.00% | New | 15,553 | $10K |
| Virtu Financial LLC | 0.00% | New | 16,042 | $10K |
| HRT Financial LP | 0.00% | New | 14,316 | $9K |
| SBI Securities Co., Ltd. | 0.00% | — | 4,127 | $3K |
| JPMorgan Chase & Co. | 0.00% | New | 1,679 | $1K |
| GAMMA Investing LLC | 0.00% | New | 1,225 | $790 |
| Rhumbline Advisers | 0.00% | New | 1,081 | $696 |
| Harbour Investments, Inc. | 0.00% | No change | 236 | $152 |
| New England Capital Financial Advisors LLC | 0.00% | No change | 201 | $130 |
| Truvestments Capital LLC | 0.00% | New | 200 | $129 |
| Wells Fargo & Company | 0.00% | Add +2700.0% | 140 | $90 |
| Toth Financial Advisory Corp. | 0.00% | New | 30 | $20 |
"% of holder's portfolio" is TC BIOPHARM HOLDINGS PLC's weight in each manager's 13F, not the share of TC Biopharm Holdings PLC the manager owns.